Office of Research on Women's Health (ORWH)
Janine Austin Clayton, M.D.
Director, Office of Research on Women’s Health
Janine Austin Clayton, M.D., was appointed Director for the NIH Office of Research on Women’s Health (ORWH) and Associate Director for NIH Research on Women’s Health by NIH Director Francis S. Collins, M.D., Ph.D., on September 4, 2012. Dr. Clayton served as ORWH acting director beginning August 2011, when Vivian Pinn, M.D., the first full-time ORWH director, retired. Prior to her tenure as acting director, Dr. Clayton served as the ORWH deputy director for three years. Dr. Clayton currently co-chairs the NIH Working Group on Women in Biomedical Careers with the NIH director.
Prior to joining ORWH, Dr. Clayton was the deputy clinical director of the National Eye Institute, NIH. A board certified ophthalmologist, Dr. Clayton’s research interests include autoimmune ocular diseases and the role of sex and gender in health and disease, with a particular interest in ocular surface disease. Dr. Clayton discovered a novel form of disease associated with premature ovarian insufficiency that affects young women. She is the author of more than 80 scientific publications, journal articles, and book chapters.
Dr. Clayton is a native Washingtonian. She received her undergraduate degree with honors from the Johns Hopkins University and her medical degree from Howard University College of Medicine. She completed a residency in ophthalmology at the Medical College of Virginia and fellowship training in cornea and external disease at the Johns Hopkins Hospital’s Wilmer Eye Institute and in uveitis and ocular immunology at the National Eye Institute.
Dr. Clayton has been an attending physician and clinical investigator in cornea and uveitis at the NEI since 1996 where she conducts research on inflammatory diseases of the anterior segment and provides medical and surgical uveitis fellowship training. Her clinical research ranges from randomized controlled trials of novel therapies for immune mediated ocular diseases to studies on the development of digital imaging techniques for the anterior segment.
Dr. Clayton is a Fellow of the New York Academy of Medicine. She currently serves on the FDA Advisory Panel for Ophthalmic Devices; the medical and scientific advisory board of Tissue Banks International; the editorial board of The Ocular Surface, and the executive committee of WomensEyeHealth.org .
The Association for Research in Vision and Ophthalmology selected Dr. Clayton as a Silver Fellow, and she is a recipient of the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Clayton has received several awards from her NIH peers in recognition of her leadership.